C. Huerta

发表

A. Bate, J. Hallas, G. Requena, 2009, 2009 Device Research Conference.

Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project

S. de Lusignan, C. Huerta, R. Gini, 2021, Drug Safety.

Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project.

C. Huerta, M. Lehtinen, R. Gini, 2020, Vaccine.

Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism

C. Huerta, M. Wallander, S. Johansson, 2008, Thrombosis journal.

Methodological comparison of marginal structural model, time‐varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture

A. Hoes, H. Gardarsdottir, P. Souverein, 2016, Pharmacoepidemiology and drug safety.

Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross‐national descriptive study from the PROTECT‐EU Project

A. Bate, G. Requena, H. Gardarsdottir, 2016, Pharmacoepidemiology and drug safety.

Risk of irritable bowel syndrome among asthma patients

C. Huerta, M. Wallander, S. Johansson, 2002, Pharmacoepidemiology and drug safety.

Respiratory medications and risk of asthma death

C. Huerta, L. G. García Rodríguez, S. Lanes, 2002, Thorax.

The risk of obstructive airways disease in a glaucoma population

C. Huerta, L. G. García Rodríguez, F. Arellano, 2001, Pharmacoepidemiology and drug safety.

Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008–2015)

H. Gardarsdottir, P. Souverein, C. Huerta, 2021, Frontiers in Pharmacology.

Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban—A European comparative drug utilization study

H. Gardarsdottir, P. Souverein, C. Huerta, 2020, Basic & clinical pharmacology & toxicology.

Risk of Acute Liver Injury in Patients with Diabetes

C. Huerta, Luis A. Rodriguez, Sean Z. Zhao, 2002, Pharmacotherapy.

Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications

A. Egberts, G. Requena, H. Gardarsdottir, 2014, European Journal of Clinical Pharmacology.

Impact of pre‐exposure time bias in self‐controlled case series when the event conditions the exposure: Hip/femur fracture and use of benzodiazepines as a case study

G. Requena, C. Huerta, I. Douglas, 2020, Pharmacoepidemiology and drug safety.

Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008–2015): A cross‐national drug utilization study

H. Gardarsdottir, P. Souverein, C. Huerta, 2019, British journal of clinical pharmacology.

Do case‐only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepines†

A. Bate, G. Requena, J. Logie, 2015, Pharmacoepidemiology and drug safety.

Lipid-Lowering Drugs and Risk of Myopathy: A Population-Based Follow-Up Study

J. Hallas, C. Huerta, S. Sindrup, 2001, Epidemiology.

Prevalence of antibiotic use: a comparison across various European health care data sources

L. Smeeth, A. Bate, G. Requena, 2015, Pharmacoepidemiology and drug safety.

Seasonal changes in prescribing of long-acting beta-2-agonists-containing drugs.

J. Hasford, G. Requena, C. Huerta, 2015, Respiratory medicine.

Use of hydrochlorothiazide and risk of skin cancer in a large nested case‐control study in Spain

C. Huerta, A. Pottegård, L. León-Muñoz, 2021, Pharmacoepidemiology and drug safety.

Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?

J. Hallas, C. Huerta, S. Sindrup, 2001, European Journal of Clinical Pharmacology.

Respiratory Medications and the Risk of Cardiac Arrhythmias

C. Huerta, L. G. García Rodríguez, S. Lanes, 2005, Epidemiology.

For peer review only ORAL BISPHOSPHONATES ARE ASSOCIATED WITH INCREASED RISK OF ATYPICAL FEMORAL FRACTURES IN ELDERLY WOMEN

C. Huerta, M. Gil, B. Oliva, 2012 .

Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom.

C. Huerta, M. Wallander, S. Johansson, 2007, Archives of internal medicine.

Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case–control studies using two primary care databases in Europe

L. Smeeth, A. Bate, C. Huerta, 2016, Pharmacoepidemiology and drug safety.

A strategy for assessment and validation of major bleeding cases in a primary health care database in Spain

C. Huerta, V. Bryant, Airam de Burgos-González, 2021, Pharmacoepidemiology and drug safety.

A Validation Study on the Frequency and Natural History of Miscarriages Using the Spanish Primary Care Database BIFAP

C. Huerta, L. Cea-Soriano, P. Ortega, 2021, Healthcare.

Ascertainment of acute liver injury in two European primary care databases

A. Bate, G. Requena, C. Huerta, 2014, European Journal of Clinical Pharmacology.

Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case–control study

C. Huerta, Á. Alonso, F. D. de Abajo, 2013, BMJ Open.

For peer review only 1 TITLE ORAL BISPHOSPHONATES ARE ASSOCIATED WITH INCREASED RISK OF ATYPICAL FEMORAL FRACTURES IN ELDERLY WOMEN

C. Huerta, Á. Alonso, F. Abajo, 2012 .

The role of prenatal exposure to antidepressants, anxiolytic, and hypnotics and its underlying illness on the risk of miscarriage using BIFAP database

C. Huerta, L. Cea-Soriano, P. Ortega, 2022, Pharmacoepidemiology and drug safety.

Users of oral steroids are at a reduced risk of developing irritable bowel syndrome

C. Huerta, M. Wallander, S. Johansson, 2003, Pharmacoepidemiology and drug safety.

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

P. Souverein, C. Huerta, I. Douglas, 2022, Frontiers in Pharmacology.

Risk factors for intestinal ischaemia among patients registered in a UK primary care database: a nested case–control study

C. Huerta, E. Rivero, L. García‐Rodríguez, 2011, Alimentary pharmacology & therapeutics.

Incidence and risk factors for psoriasis in the general population.

Consuelo Huerta, C. Huerta, Luis A. Rodriguez, 2007, Archives of dermatology.

Base de Datos para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP): A data resource for pharmacoepidemiology in Spain

C. Huerta, E. Martín-Merino, Miguel-Angel Maciá-Martínez, 2020, Pharmacoepidemiology and drug safety.

An algorithm to identify pregnancies in BIFAP Primary Care database in Spain: Results from a cohort of 155 419 pregnancies

C. Huerta, P. Astasio, L. Cea Soriano, 2019, Pharmacoepidemiology and drug safety.

Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation – A contribution of the ADVANCE-project

Consuelo Huerta, Kaatje Bollaerts, Miriam Sturkenboom, 2019, PloS one.

Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population.

C. Huerta, L. G. García Rodríguez, J. Castellsagué, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation

H. Gardarsdottir, P. Souverein, C. Huerta, 2020, British journal of clinical pharmacology.

Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines

Ehrenstein, H. Gardarsdottir, P. Souverein, 2021 .

Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population‐based cohort studies

H. Gardarsdottir, P. Souverein, C. Huerta, 2021, Pharmacoepidemiology and drug safety.

Incidence of ocular melanoma in the general population and in glaucoma patients

C. Huerta, L. A. Rodríguez, 2001, Journal of epidemiology and community health.

The recording of human papillomavirus (HPV) vaccination in BIFAP primary care database: A validation study

C. Huerta, D. Montero-Corominas, E. Martín-Merino, 2018, Pharmacoepidemiology and drug safety.

Antiepileptic drug use in seven electronic health record databases in Europe: A methodologic comparison

G. Requena, P. Souverein, C. Huerta, 2014, Epilepsia.

Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT‐EU project

A. Bate, G. Requena, J. Logie, 2016, Pharmacoepidemiology and drug safety.

Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study

C. Huerta, R. Gini, C. Giaquinto, 2022, Vaccine.

A new risk of bias checklist applicable to randomized trials, observational studies, and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events.

C. Huerta, M. Martínez-Zapata, X. Vidal, 2017, Journal of clinical epidemiology.

Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population

C. Huerta, L. G. García Rodríguez, J. Castellsagué, 2006, Heart.

Incidence Rates and Trends of Hip/Femur Fractures in Five European Countries: Comparison Using E-Healthcare Records Databases

A. Bate, G. Requena, H. Gardarsdottir, 2014, Calcified Tissue International.

BIFAP Program: A Data Resource for Pharmacoepidemiological Research in Spain

C. Huerta, E. Martín-Merino, M. Macía, 2021 .

Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures

G. Requena, J. Logie, H. Gardarsdottir, 2016, Pharmacoepidemiology and drug safety.

Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain

C. Huerta, L. Sordo, J. Pulido, 2022, Pharmacoepidemiology and drug safety.

Case‐only designs for studying the association of antidepressants and hip or femur fracture

A. Hoes, H. Gardarsdottir, P. Souverein, 2016, Pharmacoepidemiology and drug safety.

Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project

S. de Lusignan, C. Huerta, R. Gini, 2021, Drug Safety.

Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study

H. Gardarsdottir, P. Souverein, C. Huerta, 2023, Drug Safety.

Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis

C. Huerta, R. Gini, M. Sturkenboom, 2023, Frontiers in Pharmacology.

Incidence of Direct Oral Anticoagulant use in patients with non-valvular atrial fibrillation and characteristics of users in six European countries (2008-2015) A cross-national drug utilization study

P. Souverein, C. Huerta, C. Gasse, 2019 .

Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross‐national descriptive study from the PROTECT‐EU Project

A. Bate, G. Requena, H. Gardarsdottir, 2016, Pharmacoepidemiology and Drug Safety.

Incidence Rates and Trends of Hip/Femur Fractures in Five European Countries: Comparison Using E-Healthcare Records Databases

A. Bate, G. Requena, H. Gardarsdottir, 2014, Calcified Tissue International.

Abstracts

G. Requena, H. Gardarsdottir, P. Souverein, 2000, Blood Purification.